Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells

Oncology Reports

Volumn 27, Issue 1, 2012, Pages 143-150

  Du, Hailei ^a   Yang, Weiping ^a   Chen, Lin ^a   Shi, Mingming ^a   Seewoo, Varun ^a   Wang, Jiayu ^a   Lin, Andy ^a   Liu, Zhuoran ^a   Qiu, Weihua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; ATG7; Autophagy; Hepatocellular carcinoma; Oxaliplatin

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; OXALIPLATIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATG7 GENE; AUTOPHAGY; CANCER INHIBITION; CANCER RESISTANCE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; DRUG SENSITIVITY; GENE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IMMUNOFLUORESCENCE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DRUG RESISTANCE, NEOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; ORGANOPLATINUM COMPOUNDS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84855267962     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1464     Document Type: Article

References (30)

1. Caldwell S and Park SH: The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 19: 96-101, 2009.
2. McGlynn KA and London WT: Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19: 3-23, 2005. (Pubitemid 40331495)
3. Kudo M: Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Oncology 75: 1-12, 2008.
4. Lee JG, Choi SB, Kim KS, Choi JS, Lee WJ and Kim BR: Central bisectionectomy for centrally located hepatocellular carcinoma. Br J Surg 95: 990-995, 2008.
5. Roberts LR: Sorafenib in liver cancer - just the beginning. N Engl J Med 359: 420-422, 2008.
6. Misset JL, Bleiberg H, Sutherland W, Bekradda M and Cvitkovic E: Oxaliplatin clinical activity: a review. Crit Rev Oncol Hematol 35: 75-93, 2000. (Pubitemid 30599431)
7. Louaf S, Boige V, Ducreux M, et al.: Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study. Cancer 109: 1384-1390, 2007. (Pubitemid 46466566)
8. Tsuchihara K, Fujii S and Esumi H: Autophagy and cancer: dynamism of the metabolism of tumor cells and tissues. Cancer Lett 278: 130-138, 2009.
9. Apel A, Zentgraf H, Büchler MW and Herr I: Autophagy-A double-edged sword in oncology. Int J Cancer 125: 991-995, 2009.
10. Yousefi S and Simon HU: Autophagy in cancer and chemotherapy. Results Probl Cell Differ 49: 183-190, 2009.
11. Qiu W, David D, Zhou B, et al.: Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol 162: 1961-1974, 2003. (Pubitemid 36613053)
12. Shvets E and Elazar Z: Autophagy-independent incorporation of GFP-LC3 into protein aggregates is dependent on its interaction with p62/SQSTM1. Autophagy 16: 1054-1056, 2008.
13. Kabeya Y, Mizushima N and Ueno T: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728, 2000.
14. Komatsu M, Waguri S, Ueno T, et al.: Impairment of starvation-induced and constitutive autophagy in ATG7-deficient mice. J Cell Biol 169: 425-434, 2005. (Pubitemid 40686693)
15. Qiu W, Zhou B, Zou H, et al.: Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma. Am J Pathol 165: 1689-1699, 2004. (Pubitemid 39435167)
16. Karim MR, Kanazawa T, Daigaku Y, Fujimura S, Miotto G and Kadowaki M: Cytosolic LC3 ratio as a sensitive index of macroautophagy in isolated rat hepatocytes and H4-II-E cells. Autophagy 3: 553-560, 2007. (Pubitemid 350060051)
17. Olivé M, van Leeuwen FW, Janué A, Moreno D, Torrejón-Escribano B and Ferrer I: Expression of mutant ubiquitin (UBB+1) and p62 in myotilinopathies and desminopathies. Neuropathol Appl Neurobiol 34: 76-87, 2008.
18. Bjørkøy G, Lamark T, Brech A, et al.: p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on Huntingtin-induced cell death. J Cell Biol 171: 603-614, 2005. (Pubitemid 41668720)
19. Boige V, Raoul JL, Pignon JP, et al.: Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial. Br J Cancer 97: 862-867, 2007.
20. Wang Z, Zhou J, Fan J, et al.: Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opin Investig Drugs 18: 1595-1604, 2009.
21. Bruix J, Hessheimer AJ, Forner A, Boix L, Vilana R and Llovet JM: New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 25: 3848-3856, 2006. (Pubitemid 43980480)
22. Ding WX, Ni HM, Gao W, et al.: Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem 282: 4702-4710, 2007. (Pubitemid 47101001)
23. Ogier-Denis E and Codogno P: Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 1603: 113-128, 2003. (Pubitemid 36266686)
24. Abedin MJ, Wang D, McDonnell MA, Lehmann U and Kelekar A: Autophagy delays apoptotic cell death in breast cancer cells following DNA damage. Cell Death Differ 22: 500-510, 2006.
25. Arango D, Wilson AJ, Shi Q, et al.: Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br J Cancer 91: 1931-1946, 2004. (Pubitemid 40065523)
26. Lee JS, Chu IS, Heo J, et al.: Classification and prediction of survival in hepatocellular carcinoma by gene expression profling. Hepatology 40: 667-676, 2004. (Pubitemid 39265589)
27. Herman-Antosiewicz A, Johnson DE and Singh SV: Sulforaphane causes autophagy to inhibit release of cytochrome c and apoptosis in human prostate cancer cells. Cancer Res 66: 5828-5835, 2006. (Pubitemid 43927137)
28. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T and Kuwano H: Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 16: 761-771, 2009.
29. Komatsu M, Waguri S, Koike M, et al.: Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131: 1149-1163, 2007. (Pubitemid 350235021)
30. Mathew R, Karp CM, Beaudoin B, et al.: Autophagy suppresses tumorigenesis through elimination of p62. Cell 137: 1062-1075, 2009.